COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion

Authors:
  • XMXicheng Mao
    Xicheng Mao
  • YZYali Zhai
    Yali Zhai
  • AGArjan J. Groot
    Arjan J. Groot
  • JVJeroen F. Vermeulen
    Jeroen F. Vermeulen
  • EWElsken van der Wall
    Elsken van der Wall
  • PDPaul J. van Diest
    Paul J. van Diest
  • MHMarten H. Hofker
    Marten H. Hofker
  • LKLeo W. Klomp
    Leo W. Klomp
  • EFEric R. Fearon
    Eric R. Fearon

Abstract
The gene encoding COMM domain–containing 1 (COMMD1) is a prototypical member of the COMMD gene family that has been shown to inhibit both NF-κB– and HIF-mediated gene expression. NF-κB and HIF are transcription factors that have been shown to play a role in promoting tumor growth, survival, and invasion. In this study, we demonstrate that COMMD1 expression is frequently suppressed in human cancer and that decreased COMMD1 expression correlates with a more invasive tumor phenotype. We found that direct repression of COMMD1 in human cell lines led to increased tumor invasion in a chick xenograft model, while increased COMMD1 expression in mouse melanoma cells led to decreased lung metastasis in a mouse model. Decreased COMMD1 expression also correlated with increased expression of genes known to promote cancer cell invasiveness, including direct targets of HIF. Mechanistically, our studies show that COMMD1 inhibits HIF-mediated gene expression by binding directly to the amino terminus of HIF-1α, preventing its dimerization with HIF-1β and subsequent DNA binding and transcriptional activation. Altogether, our findings demonstrate a role for COMMD1 in tumor invasion and provide a detailed mechanism of how this factor regulates the HIF pathway in cancer cells.

This publication has 48 references indexed in Scilit: